Zach Galliger and Allie Kolberg both presented fantastic posters, Andrew Shoffstall gave a talk, and Dr. Lavik gave an invited talk at BMES. Zach and Allie’s posters focused on using the synthetic platelets as drug delivery vehicles, Andrew’s talk focused on improving survival following trauma with synthetic platelets, and Dr. Lavik’s talk focused on developing translatable technologies such as technologies for ocular delivery and hemostatic nanoparticles.
This happened especially in those that suffered from some liver
disorder. It all comes down to treating causes instead of
symptoms. I am mainly referring to any platelet level under 25,
000 as acute stage.
Howdy! I could have sworn I’ve visited this site before but
after going through many of the posts I realized it’s new to me.
Nonetheless, I’m definitely happy I stumbled upon it and I’ll be book-marking it and checking
back frequently!
Thanks on your marvelous posting! I genuinely enjoyed reading it, you happen to be a great author.I will
make certain to bookmark your blog and will come back very soon.
I want to encourage you to continue your great posts, have a nice afternoon!